Gene transfer of cytoprotective and immunomodulatory molecules for prevention of cardiac allograft rejection

Vassalli, Giuseppe; Fleury, Sylvain; Li, Jianping; Goy, Jean-Jacques; Kappenberger, Lukas; von Segesser, Ludwig K.
November 2003
European Journal of Cardio-Thoracic Surgery;Nov2003, Vol. 24 Issue 5, p794
Academic Journal
Current treatments of heart transplantation are limited by incomplete effectiveness, significant toxicity, and failure to prevent chronic rejection. Genetic manipulation of the donor heart at the time of removal offers the unique opportunity to produce a therapeutic molecule within the graft itself, while minimizing systemic effects. Cytoprotective approaches including gene transfer of heme oxygenase (HO)-1, endothelial nitric oxide synthase, and antisense oligodeoxynucleotides specific for nuclear factor (NF)-κB or intercellular adhesion molecule (ICAM)-1 reduced ischaemia–reperfusion injury and delayed cardiac allograft rejection in small animals. Exogenous overexpression of immunomodulatory cytokines such as interleukin (IL)-4, IL-10 and transforming growth factor-β, as well as gene transfer of inhibitors of pro-inflammatory cytokines also delayed graft rejection. Gene transfer-based blockade of T-cell costimulatory activation with CTLA4-Ig or CD40-Ig resulted in long-lasting graft survival and donor-specific unresponsiveness, as manifested by acceptance of a second graft from the original donor strain but rejection of third-party grafts. Similar results were obtained with donor major histocompatibility complex class I gene transfer into bone marrow cells. Gene therapy approaches to chronic rejection included gene transfer of HO-1, soluble Fas, tissue plasminogen activator and antisense oligodeoxynucleotides specific for the anti-apoptotic mediator Bcl-x or the E2F transcription factor. Despite major experimental advances, however, gene therapy for heart transplantation has not entered the clinical arena yet. Fundamental questions regarding the most suitable vector, the best gene, and safety issues remain unanswered. Well-controlled studies that compare gene therapy with established treatments in non-human primates are needed before clinical trials can be started.


Related Articles

  • A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Schipper, Meike L.; Nakayama-Ratchford, Nozomi; Davis, Corrine R.; Wong Shi Kam, Nadine; Chu, Pauline; Zhuang Liu; Xiaoming Sun; Hongjie Dai; Gambhir, Sanjiv S. // Nature Nanotechnology;Apr2008, Vol. 3 Issue 4, p216 

    Single-walled carbon nanotubes are currently under evaluation in biomedical applications, including in vivo delivery of drugs, proteins, peptides and nucleic acids (for gene transfer or gene silencing), in vivo tumour imaging and tumour targeting of single-walled carbon nanotubes as an...

  • Bcl-xL Gene Transfer Improves Graft Survival and Prolongs the Cold-Preservation Time in the Heart Transplantation  // Molecular Therapy;May2004 Supplement 1, Vol. 9, p354 

    An abstract of the article "Bcl-xL Gene Transfer Improves Graft Survival and Prolongs the Cold-Preservation Time in the Heart Transplantation," by Jinghua Huang, Yoshinori Ito and Takeshi Uzuka is presented.

  • 47. Ex Vivo Hypothermic Recirculatory Adenoviral Gene Transfer to the Transplanted Pig Heart Oi, Keiji; Davies, William R.; Tazelaar, Henry D.; Bailey, Kent R.; Federspiel, Mark J.; Russell, Stephen J.; McGregor, Christopher G.A. // Molecular Therapy;Jun2005, Vol. 11, p20 

    An abstract of the article "Ex Vivo Hypothermic Recirculatory Adenoviral Gene Transfer to the Transplanted Pig Heart," by Keiji Oi, William R. Davies, Henry D. Tazelaar, Kent R. Bailey, Mark J. Federspiel, Stephen J. Russell and Christopher G. A. McGregor is presented.

  • Non-Viral Gene Delivery Methods: A Review. Gashti, Anahita Bakhshizadeh; Prakash, H. S. // Journal of Pharmacy Research;2012, Vol. 5 Issue 8, p4361 

    Gene therapy is emerging as a novel method for the treatment of wide range of diseases compared to conventional drug therapy. Though virus mediated gene transfer is efficient in transducing cells due to the safety concerns associated with it, non-viral delivery systems are preferred alternatives...

  • The Effect of Cationic Charge Density Change on Transfection Efficiency of Polyethylenimine. Rezvani Amin, Zohreh; Rahimizadeh, Mohammad; Eshghi, Hossein; Dehshahri, Ali; Ramezani, Mohammad // Iranian Journal of Basic Medical Sciences;Feb2013, Vol. 16 Issue 2, p150 

    Objective(s): Polyethylenimine (PEI) is a potent non-viral gene delivery carrier. PEI surface charge plays a major role in its condensation ability which in turn is a necessary requirement for high transfection efficiency. As the PEI charge density is dependent on pH, the effect of pH changing...

  • Silencing of ZnT-1 expression enhances heavy metal influx and toxicity. Ohana, Ehud; Sekler, Israel; Kaisman, Tehila; Kahn, Nicol; Cove, Joshua; Silverman, William; Amsterdam, Abraham; Hershfinkel, Michal // Journal of Molecular Medicine;Sep2006, Vol. 84 Issue 9, p753 

    ZnT-1 reduces intracellular zinc accumulation and confers resistance against cadmium toxicity by a mechanism which is still unresolved. A functional link between the L-type calcium channels (LTCC) and ZnT-1 has been suggested, indicating that ZnT-1 may regulate ion permeation through this...

  • Highly efficient cell-mediated gene transfer using non-viral vectors and FuGeneâ„¢6: in vitro and in vivo studies. Hellgren, I.; Drvota, V.; Pieper, R.; Enoksson, S.; Blomberg, P.; Islam, K. B.; Sylvén, C. // Cellular & Molecular Life Sciences;Aug2000, Vol. 57 Issue 8/9, p1326 

    The present study was undertaken to develop an efficient non-viral gene delivery system for cardiovascular gene therapy. We investigated transfection efficiency and toxic properties of the new transfection reagent, FuGeneâ„¢6, and compared it with two other transfection reagents,...

  • Over expression of the selectable marker blasticidin S deaminase gene is toxic to human keratinocytes and murine BALB/MK cells. Bento, Fernanda Mara; Takeshita, Daniela; Sacramento, Chester Bittencourt; Machado, Tamara Rocha; Mathor, Monica Beatriz; Carmona, Adriana Karaoglanovic; Sang Won Han // BMC Biotechnology;2004, Vol. 4, p29 

    Background: The blasticidin S resistance gene (bsr) is a selectable marker used for gene transfer experiments. The bsr gene encodes for blasticidin S (BS) deaminase, which has a specific activity upon BS. Therefore, its expression is supposed to be harmless in cells. The work reported on herein...

  • Adenovirus-mediated gene transfer of the β2-adrenergic receptor to donor hearts enhances cardiac function. Kypson, A P; Hendrickson, S C; Akhter, S A; Wilson, K; McDonald, P H; Lilly, R E; Dolber, P C; Glower, D D; Lefkowitz, R J; Koch, W J // Gene Therapy;Jul99, Vol. 6 Issue 7, p1298 

    Gene transfer to modify donor heart function during transplantation has significant therapeutic implications. Recent studies by our laboratory in transgenic mice have shown that overexpression of β2-adrenergic receptors (β2-ARs) leads to significantly enhanced cardiac function. Thus, we...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics